Abel Hall LLC’s ALX Oncology ALXO Stock Holding History

Abel Hall LLC’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.4K	Buy	13,977 +1,246	+10%	+$2.41K	﹤0.01%	875
2026 Q2	$26.4K	Buy	12,731 +133	+1%	+$238	﹤0.01%	934
2026 Q1	$25.3K	Hold	12,598	–	–	0.01%	784
2025 Q4	$14.2K	Hold	12,598	–	–	﹤0.01%	709
2025 Q3	$23.1K	Sell	12,598 -2,611	-17%	-$2.26K	0.01%	313
2025 Q2	$6.31K	Buy	+15,209	New	+$7.68K	﹤0.01%	287
2025 Q1	–	Sell	-10,406	Closed	-$17.4K	–	205
2024 Q4	$17.4K	Buy	+10,406	New	+$16K	0.01%	160

Other funds holding ALXO

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Abel Hall LLC's ALXO Position: Q3 2026 in Review

Abel Hall LLC increased its ALX Oncology (ALXO) stake by 9.8% in Q3 2026, buying an estimated $2.41K and bringing the position to 13,977 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Abel Hall LLC first reported a position in ALXO in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.4K in Q2 2026. 4 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

Abel Hall LLC held 13,977 shares of ALX Oncology worth $19.4K as of Q3 2026.
Abel Hall LLC bought 1,246 ALX Oncology shares in Q3 2026, an estimated $2.41K.
ALX Oncology made up ﹤0.01% of Abel Hall LLC's portfolio in Q3 2026, its #875 holding.
Abel Hall LLC first reported a position in ALX Oncology in Q4 2024 and has held it in 7 quarters since.
Abel Hall LLC's ALX Oncology position peaked at $26.4K in Q2 2026.
4 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.